.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Fuji
Daiichi Sankyo
Novartis
Boehringer Ingelheim
QuintilesIMS
Express Scripts
Farmers Insurance
McKesson
Chubb

Generated: June 28, 2017

DrugPatentWatch Database Preview

Insulin susp isophane purified pork - Generic Drug Details

« Back to Dashboard

What are the generic sources for insulin susp isophane purified pork and what is the scope of insulin susp isophane purified pork freedom to operate?

Insulin susp isophane purified pork
is the generic ingredient in three branded drugs marketed by Novo Nordisk Inc and Lilly, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for insulin susp isophane purified pork.

Summary for Generic Name: insulin susp isophane purified pork

Tradenames:3
Patents:1
Applicants:2
NDAs:3
Drug Master File Entries: see list38
Clinical Trials: see list4,210
Drug Prices:see low prices
DailyMed Link:insulin susp isophane purified pork at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
INSULIN INSULATARD NPH NORDISK
insulin susp isophane purified pork
INJECTABLE;INJECTION018194-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
NPH ILETIN II (PORK)
insulin susp isophane purified pork
INJECTABLE;INJECTION018345-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Novo Nordisk Inc
NPH PURIFIED PORK ISOPHANE INSULIN
insulin susp isophane purified pork
INJECTABLE;INJECTION018623-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Covington
Merck
Moodys
Express Scripts
Chinese Patent Office
Daiichi Sankyo
Queensland Health
QuintilesIMS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot